3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells

Area of Science:

• Immunology
• Biotechnology
• Cancer Research

Background:

• Immunotherapy effectiveness depends on tumor microenvironment interactions between cancer cells and dendritic cells (DCs).
• DCs are crucial for initiating antitumor responses by presenting tumor antigens to T cells.
• Interferon-α-conditioned DCs (IFN-DCs) show enhanced phagocytic and antigen-specific T-cell induction capabilities.

Purpose of the Study:

• To develop and utilize a novel microfluidic platform for tracking human DC behavior towards tumor cells in a 3D environment.
• To analyze the guided motion and phagocytosis of IFN-DCs in response to drug-treated cancer cells.
• To investigate underlying factors, such as CXCR4 involvement, in DC-cancer cell interactions.

Main Methods:

• Development of a microfluidic platform simulating interconnected cancer and immune systems in 3D.
• Integration of advanced microscopy techniques for real-time cell tracking.
• Application of a revised cell tracking analysis algorithm to quantify IFN-DC behavior.

Main Results:

• Demonstrated guided motion of IFN-DCs towards drug-treated cancer cells within the microfluidic platform.
• Observed and quantified phagocytosis events following DC-cancer cell interaction.
• Identified CXCR4 as a key factor influencing IFN-DC-cancer cell interactions in a 3D tumor model.

Conclusions:

• The microfluidic platform effectively dissects IFN-DC-cancer cell interactions within 3D tumor microenvironments.
• The platform offers a novel tool for assessing the efficacy of immunotherapeutic strategies.
• Understanding molecular mechanisms like CXCR4 involvement can optimize DC-based cancer therapies.